Colleen Bond, PharmD from Westchester Medical Center, and Andy Webb, PharmD of Massachusetts General Hospital, dive into the heated debate over Nicardipine and Clevidipine for neurocritical care patients. They explore the critical differences in blood pressure management between these medications, including clinical efficacy and patient outcomes. The conversation also touches on the implications of compounding practices, the importance of rapid blood pressure control, and the risks associated with Clevidipine's lipid emulsion. It's an insightful look at pharmacological choices in acute care!
